GAITHERSBURG, Md.--(BUSINESS WIRE)--Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical and chemical industries, announced that two of its leading scientists have been selected to present at a poster session at the 37th Annual Meeting of the American College of Toxicology (ACT), being held November 6-9 in Baltimore, Maryland.
Posters to be presented at the event on Monday, November 7 from 5:30 to 7 p.m. are:
- “Developmental Toxicology Validation Program Evaluating the Teratogenic Effects Produced when 6-Aminonicotinamde or Acetylsalicylic Acid are Administered to Pregnant New Zealand White Rabbits or Sprague Dawley Rats, Respectively on Specific Gestation Days,” authored by Caitlin Murphy, PhD, Michael A. Dorato, PhD, DABT, Fellow ATS, and Stephanie Goodnight, of Smithers Avanza, and Stephen B. Harris, PhD, FATS, FRSB of Stephen B. Harris Group.
- “An Intradermal Toxicity Study of a Therapeutic Nanoparticle Cancer Vaccine in Sprague Dawley Rats,” authored by C. Steven Godin, PhD, DABT, of Smithers Avanza and Solomon Stewart and Steven Fuller of Panacea Pharmaceuticals.
The American College of Toxicology is a professional organization of about 1,000 toxicologists who work in industry, pharmaceutical and biotech companies, government regulatory agencies, or as consultants. ACT’s annual meeting provides a forum for its members to share information through numerous education and networking opportunities.
“The ACT meeting is a useful venue for sharing research and learning from colleagues as we seek to stay on top of the challenges and trends happening in the toxicology industry,” said Michael Dorato, PhD, DABT, Fellow ATS, Executive Vice President, Smithers Avanza Toxicology Services. “We’re excited to present our studies on the critical topics of developmental toxicology and vaccine development and we look forward to the many other insightful and provocative posters and presentations at this year’s event.”
Smithers Avanza is a gold sponsor of the American College of Toxicology Meeting, and will exhibit in booth 215.
For additional program information for the ACT Annual Meeting, visit http://www.actox.org/am/am2016/index.asp.
For more information about the Smithers Avanza portfolio of services, visit http://smithersavanza.com.
About Smithers Avanza
Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical, agrochemical and chemical industries. Our scientists have expertise in large molecule bioanalysis, assay development, validation and sample analysis at our GLP- and GCP-compliant and CLIA-certified registered laboratory. Key expertise includes single dose to two-year general toxicology studies, vaccine safety testing, toxicokinetics, and infusion studies.
